verapamil has been researched along with aliskiren in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dahlke, M; Hariry, S; Jarugula, V; Leon, S; Rebello, S | 1 |
| De Mello, W | 1 |
1 review(s) available for verapamil and aliskiren
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for verapamil and aliskiren
| Article | Year |
|---|---|
Effect of verapamil on the pharmacokinetics of aliskiren in healthy participants.
Topics: Administration, Oral; Adolescent; Adult; Amides; Antihypertensive Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Drug Interactions; Fumarates; Humans; Male; Prospective Studies; Verapamil; Young Adult | 2011 |
1 other study(ies) available for verapamil and aliskiren
| Article | Year |
|---|---|
Intracellular renin increases the inward calcium current in smooth muscle cells of mesenteric artery of SHR. Implications for hypertension and vascular remodeling.
Topics: Amides; Angiotensin II; Animals; Calcium; Calcium Signaling; Disease Models, Animal; Fumarates; Humans; Hypertension; Mesenteric Arteries; Myocytes, Smooth Muscle; Rats; Renin; Vascular Remodeling; Verapamil | 2016 |